Enlivex Therapeutics Ltd. (ENLV)
0.20
-0.02 (9.09%)
Upcoming Events
Latest Headlines
Form 6-K Enlivex Ltd. For: Oct 19
October 19, 2026 8:18 AM - SEC Filing
Enlivex cuts 60% of workforce to focus on knee OA trial
October 19, 2026 8:17 AM - StreetInsider
Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
October 19, 2026 8:17 AM - StreetInsider
Form 6-K/A Enlivex Ltd. For: Oct 02
October 2, 2026 4:16 PM - SEC Filing
Form 6-K/A Enlivex Ltd. For: Sep 30
October 1, 2026 6:02 AM - SEC Filing
Form 6-K Enlivex Ltd. For: Sep 29
September 29, 2026 5:11 PM - SEC Filing
Form 6-K Enlivex Ltd. For: Jun 30
September 25, 2026 4:16 PM - SEC Filing
Form 6-K Enlivex Ltd. For: Sep 22
September 22, 2026 8:03 AM - SEC Filing
Enlivex terminates share sale deal with Rain Foundation
September 22, 2026 8:00 AM - StreetInsider
Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens
September 22, 2026 8:00 AM - StreetInsider
Form 424B3 Enlivex Ltd.
August 17, 2026 6:14 AM - SEC Filing
Form EFFECT Enlivex Ltd.
August 14, 2026 6:14 AM - SEC Filing
Form SCHEDULE 13G Enlivex Ltd. Filed by: Lind Partners LLC
August 13, 2026 4:05 PM - SEC Filing
Form 6-K Enlivex Ltd. For: Aug 11
August 11, 2026 4:15 PM - SEC Filing
Form F-3 Enlivex Ltd.
August 6, 2026 4:45 PM - SEC Filing
Enlivex Therapeutics (ENLV) PT Raised to $80 at H.C. Wainwright
August 3, 2026 6:56 AM - StreetInsider
Form 6-K Enlivex Ltd. For: Jul 30
July 30, 2026 8:02 AM - SEC Filing
Form 6-K Enlivex Ltd. For: Jul 29
July 29, 2026 8:03 AM - SEC Filing
Form 6-K Enlivex Ltd. For: Jul 28
July 28, 2026 4:41 PM - SEC Filing
Enlivex plans $400M private placement tied to crypto tokens
July 28, 2026 8:02 AM - StreetInsider
Form 6-K Enlivex Ltd. For: Jul 28
July 28, 2026 8:02 AM - SEC Filing
Full Article List
